Skye Bioscience, Inc. (SKYE) Financials

$1.84

$0.06 (3.37%)

As on 04-Sep-2026 10:31EDT

Market cap

$8 Mln

Revenue (TTM)

$0 Mln

P/E Ratio

--

P/B Ratio

2

Div. Yield

0 %

Annual
Quarterly

Income Statement ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Operating Revenue	--	--	--	--	--	--
Cost of Revenue	0.35	0.72	0.30	0.12	0.11	0.03
Gross Profit	-0.35	-0.72	-0.30	-0.12	-0.11	-0.03
Operating Expenses	51.72	57.44	30.19	34.74	18.31	7.85
Operating Profit (EBIT)	-51.90	-58.16	-30.19	-34.74	-18.31	-7.85
Other Income	--	--	--	--	--	--
Profit before Tax	-50.49	-55.92	-26.56	-37.64	-19.47	-8.52
Provision for Tax	0.00	0.01	0.01	0.00	0.01	0.00
Profit after Tax (Net Income)	-50.49	-55.92	-26.57	-37.64	-19.48	-8.52
Minority Interest	--	--	--	--	--	--
Consolidated Profit	--	--	--	--	--	-8.52

Liabilities ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Shareholder's Funds	-0.50	20.02	68.15	-2.13	-3.01	5.86
Minority Interest	--	--	--	--	--	--
Non-Current Liabilities	--	0.08	0.27	0.17	1.75	0.08
Current Liabilities	11.53	8.21	4.34	13.90	12.12	3.91
Total Liabilities	22.56	28.31	72.76	11.94	9.11	9.86

Assets ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Non-Current Assets	0.07	1.22	1.94	0.29	0.17	0.24
Current Assets	10.96	27.09	70.83	11.65	8.94	9.61
Total Assets	21.99	28.31	72.76	11.94	9.11	9.86
Total Debt*	0.04	0.27	0.46	4.62	1.93	2.14
Net Current Assets	--	18.89	66.49	-2.25	-3.18	5.70

Cashflow ($ Mln)	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Cash From Operating Activities	--	-43.06	-25.24	-13.95	-12.74	-6.47
Cash Flow from Investing Activities	--	-19.50	-0.25	6.60	5.21	-0.09
Cash from Financing Activities	--	0.03	83.56	16.44	-0.21	13.08
Net Cash Inflow / Outflow	--	--	--	--	--	--

Financials Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Adjusted EPS ($)	-10.18	-11.28	-0.66	-3.05	-0.02	-5.15
Cash EPS ($)	--	-11.13	-0.66	-3.04	-0.02	-5.13
Adjusted Book Value ($)	--	4.04	1.71	--	--	3.54
Dividend per Share ($)	--	--	--	--	--	--
Cash Flow per Share ($)	--	-8.69	-0.63	-1.13	-0.01	-3.91
Free Cash Flow per Share ($)	--	-8.69	-0.67	-1.13	-0.01	-3.96

Profitability Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
ROCE (%)	--	-125.81	-74.74	-5,368.36	-563.12	-171.32
ROE (%)	--	-126.85	-80.48	1,464.81	-1,364.20	-269.90
ROA (%)	-122.46	-110.66	-62.73	-357.64	-205.44	-136.06
EBIT Margin (%)	--	--	--	--	--	--
Net Margin (%)	--	--	--	--	--	--
Cash Profit Margin (%)	--	--	--	--	--	--

Growth Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Revenue Growth (%)	--	--	--	--	--	--
EBIT Growth (%)	5.74	-118.53	30.36	-95.33	-142.64	-32.46
Net Profit Growth (%)	-19.16	-110.50	29.43	-93.23	-128.60	-29.89
EPS Growth (%)	-852.75	-15.97	0.78	-151.04	1.00	0.11
Book Value Growth (%)	-109.10	--	--	--	--	--

Valuation Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Price / Earnings	--	-0.07	-4.26	-0.89	-0.80	-0.01
Price / Book Value	1.96	0.19	1.66	-15.76	-5.17	0.01
Dividend Yield (%)	--	--	--	--	--	--
EV/EBITDA	-2.56	0.39	-1.79	-1.26	-0.87	0.88
Close Price ($)	5.55	6.00	22.64	21.76	0.13	0.42
High Price ($)	39.92	46.00	155.28	80.00	0.54	2.07
Low Price ($)	4.52	5.48	18.00	0.06	0.09	0.31
Market Cap ($ Cr)	7.86	--	--	--	--	--

Solvency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debt to Equity	--	0.01	0.01	-2.16	-0.64	0.36
Short term debt to equity ratio	-0.07	0.01	0.00	-2.08	-0.64	0.35
Current Ratio	0.95	3.30	16.32	0.84	0.74	2.46
Quick Ratio	0.95	--	--	0.83	0.14	--
Interest Coverage	-9,182.19	--	-26.45	-40.54	-28.34	-10.10

Operating Efficiency Ratios	TTM	Dec-25	Dec-24	Dec-23	Dec-22	Dec-21	Dec-20	Dec-19	Dec-18	Dec-17	Dec-16
Debtors to sales (%)	--	--	--	--	--	--
Asset Turnover	--	--	--	--	--	--
Receivable days	--	--	--	--	--	--
Inventory Days	--	--	153.84	10,786.67	22,909.68	--
Payable days	--	657.10	933.19	4,044.40	4,279.71	6,856.30
Cash Conversion Cycle	--	--	--	--	--	--

*TTM (Trailing Twelve Months) data based on income statement of last 4 quarters and interim half yearly balance sheet.